Basho Chandan 4

What Happened Basho Chandan, Astrana Health’s COO and CFO, surrendered 1,240 shares on March 5, 2026 to satisfy tax withholding obligations tied to restricted stock units that vested the same day. The shares were valued at $25.07 each for a total of $31,087. This was a tax-withholding disposition (code F), not a voluntary open-market sale.

Key Details

• Transaction date and price: March 5, 2026 — 1,240 shares at $25.07 each; total $31,087.
• Transaction type: F (surrender of shares to cover tax withholding on vested RSUs).
• Filing date: March 9, 2026 (filed with the SEC; timing appears timely for a Form 4 filing).
• Shares owned after transaction: not specified in the filing.
• Footnote F1: Confirms shares were surrendered to offset tax withholding on RSUs that vested March 5, 2026.
• Footnote F2: Lists substantial unvested awards remaining — e.g., 7,214 shares vesting April 14, 2026; 30,404 shares vesting in two equal installments on May 16, 2026 and 2027; and multiple RSU tranches (19,504 and 20,027 units) vesting semi‑annually starting April 2, 2026 and Sept 5, 2026, respectively.

Context This was a routine tax-withholding share surrender tied to RSU vesting (often called a cashless or share‑surrender settlement) rather than an opportunistic sale. Such transactions are common when equity awards vest and do not necessarily signal the insider’s view on the company’s outlook.